Recombinant protein production in baculovirus/insect expression system

Interested in producing recombinant proteins in baculovirus/insect cell expression system? Join this complementary webinar on using the baculovirus/insect expression system for your recombinant protein expression. Learn from the expert on the baculovirus manipulation to improve protein expression and quality as well as the different strains and vectors involved. With this webinar, you will gain better understanding on when to choose insect expression over E. coli, yeast and mammalian expression system and how to trouble shoot when problems occurred.

Speaker-related Webinars

Introduction to immune checkpoints – the new hot target for cancer immunotherapy

Development of therapeutic antibodies against immune checkpoints for the treatment of melanoma and other cancers is gaining momentum among academia and the pharmaceutical industry.

Learn More

Leveraging GenScript’s cytokines, antibodies, and protein purification tools to explore Ideas for your next grant

Wouldn't it be great if all the supplies you needed to obtain preliminary data for your next grant were available from the same vendor? This webinar will show you how to incorporate

Learn More

Recombinant protein applications: choosing the best cytokine, growth factor or chemokine for your experimental system

Are you treating cells in vitro? Do your in vivo studies investigate changes in the immune response or tumor growth?

Learn More

Stem cell culture: choosing the best conditions for optimal expansion and differentiation

Are you finding your rate of stem cell differentiation to be less than optimal? Choosing the appropriate conditions for stem cell expansion and differentiation is critical for obtaining a high yield of properly differentiated cells

Learn More

Biologics Drug Discovery: Steps to Achieving an Antibody Drug Candidate

In the past decade, drug discovery has focused on developing biologics. In particular, antibody therapeutics have been proven to be clinically effective for disease areas such as oncology and immunology.

Learn More